Regina Hoo1,2,3, Kevin L M Chua4,5, Pankaj Kumar Panda6

  • 1Division of Medical Oncology, National Cancer Centre Singapore, Singapore.

Cancer discovery
|April 4, 2024
PubMed
概括

传统的临床试验终点错过了关键的治疗效果. 机制驱动的生物标志物和替代终点为精确疗法提供了对抗瘤活性更好的洞察力.